Current perspectives with pemetrexed in thoracic malignancies

Chandra Belani

doi:10.3816/CLC.2004.s.001

Current perspectives with pemetrexed in thoracic malignancies

Chandra Belani

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	S45
Journal	Clinical Lung Cancer
Volume	5
Issue number	SUPPL. 2
DOIs	https://doi.org/10.3816/CLC.2004.s.001
State	Published - Apr 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

Access to Document

10.3816/CLC.2004.s.001

Cite this

@article{15fac4c13c034ddcb93690ad3eaece39,

title = "Current perspectives with pemetrexed in thoracic malignancies",

author = "Chandra Belani",

year = "2004",

month = apr,

doi = "10.3816/CLC.2004.s.001",

language = "English (US)",

volume = "5",

pages = "S45",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier Inc.",

number = "SUPPL. 2",

}

TY - JOUR

T1 - Current perspectives with pemetrexed in thoracic malignancies

AU - Belani, Chandra

PY - 2004/4

Y1 - 2004/4

UR - https://www.scopus.com/pages/publications/2342658476

UR - https://www.scopus.com/pages/publications/2342658476#tab=citedBy

U2 - 10.3816/CLC.2004.s.001

DO - 10.3816/CLC.2004.s.001

M3 - Editorial

AN - SCOPUS:2342658476

SN - 1525-7304

VL - 5

SP - S45

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - SUPPL. 2

ER -

Current perspectives with pemetrexed in thoracic malignancies

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this